Implications of peptide assemblies in amyloid diseases

Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Käkinen; Ibrahim Javed; Frances Separovic; Thomas P. Davis; Raffaele Mezzenga

doi:10.1039/c7cs00372b

journal article Jan 01, 2017

Implications of peptide assemblies in amyloid diseases

Pu Chun Ke

Marc-Antonie Sani Feng Ding

Chemical Society Reviews Vol. 46 No. 21 pp. 6492-6531 · Royal Society of Chemistry (RSC)

View at Publisher Save 10.1039/c7cs00372b

Abstract

We highlight the role of molecular self-assembly in eliciting the mesoscopic and pathological properties of amyloid proteins. This knowledge is pivotal for the development of theranostics against amyloid diseases.

Topics

No keywords indexed for this article. Browse by subject →

References

524

[1]

The amyloid state and its association with protein misfolding diseases

Tuomas P. J. Knowles, Michele Vendruscolo, Christopher M. Dobson

Nature Reviews Molecular Cell Biology 2014 10.1038/nrm3810

[2]

Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism

Samuel I. A. Cohen, Sara Linse, Leila M. Luheshi et al.

Proceedings of the National Academy of Sciences 2013 10.1073/pnas.1218402110

[3]

An Analytical Solution to the Kinetics of Breakable Filament Assembly

Tuomas P. J. Knowles, Christopher A. Waudby, Glyn L. Devlin et al.

Science 2009 10.1126/science.1178250

[4]

Amyloid fibril formation by an SH3 domain

J. Iñaki Guijarro, Margaret Sunde, Jonathan A. Jones et al.

Proceedings of the National Academy of Sciences 1998 10.1073/pnas.95.8.4224

[5]

Designing conditions for in vitro formation of amyloid protofilaments and fibrils

Fabrizio Chiti, Paul Webster, Niccolò Taddei et al.

Proceedings of the National Academy of Sciences 1999 10.1073/pnas.96.7.3590

[6]

Urbanc Proc. Natl. Acad. Sci. U. S. A. (2004) 10.1073/pnas.0408153101

[7]

Auer PLoS Comput. Biol. (2008) 10.1371/journal.pcbi.1000222

[8]

Ratha J. Biol. Chem. (2016) 10.1074/jbc.m116.742460

[9]

Hamley Angew. Chem., Int. Ed. (2007) 10.1002/anie.200700861

[10]

Hamley Chem. Rev. (2012) 10.1021/cr3000994

[11]

Alzheimer Clin. Anat. (1995) 10.1002/ca.980080612

[12]

Glenner Biochem. Biophys. Res. Commun. (1984) 10.1016/s0006-291x(84)80190-4

[13]

Blessed Br. J. Psychiatry (1968) 10.1192/bjp.114.512.797

[14]

Grundke-Iqbal Proc. Natl. Acad. Sci. U. S. A. (1986) 10.1073/pnas.83.13.4913

[15]

Skrabana Cell. Mol. Neurobiol. (2006) 10.1007/s10571-006-9083-3

[16]

Avila Expert Opin. Ther. Targets (2016) 10.1517/14728222.2016.1131269

[17]

Mukrasch PLoS Biol. (2009) 10.1371/journal.pbio.1000034

[18]

Ganguly J. Phys. Chem. B (2015) 10.1021/acs.jpcb.5b00175

[19]

Li Biochemistry (2006) 10.1021/bi061422+

[20]

Mandelkow Brain Pathol. (2007) 10.1111/j.1750-3639.2007.00053.x

[21]

Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif ( 306 VQIVYK 311 ) forming β structure

M. von Bergen, P. Friedhoff, J. Biernat et al.

Proceedings of the National Academy of Sciences 2000 10.1073/pnas.97.10.5129

[22]

Minoura Eur. J. Biochem. (2004) 10.1046/j.1432-1033.2003.03956.x

[23]

Adamcik Angew. Chem., Int. Ed. (2016) 10.1002/anie.201508968

[24]

Sibille Proteins (2012) 10.1002/prot.23210

[25]

Sandbrink Neurobiol. Dis. (1994) 10.1006/nbdi.1994.0003

[26]

Tanzi Nature (1988) 10.1038/331528a0

[27]

Burger Am. J. Pathol. (1973)

[28]

Selkoe Annu. Rev. Cell Biol. (1994) 10.1146/annurev.cb.10.110194.002105

[29]

Zheng Cell (1995) 10.1016/0092-8674(95)90073-x

[30]

White Brain Res. (1999) 10.1016/s0006-8993(99)01861-2

[31]

Grimm Nat. Cell Biol. (2005) 10.1038/ncb1313

[32]

Meziane Proc. Natl. Acad. Sci. U. S. A. (1998) 10.1073/pnas.95.21.12683

[33]

Roch Proc. Natl. Acad. Sci. U. S. A. (1994) 10.1073/pnas.91.16.7450

[34]

Nikolaev Nature (2009) 10.1038/nature07767

[35]

Ring J. Neurosci. (2007) 10.1523/jneurosci.1026-07.2007

[36]

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Robert Vassar, Brian D. Bennett, Safura Babu-Khan et al.

Science 1999 10.1126/science.286.5440.735

[37]

Olubiyi J. Phys. Chem. B (2012) 10.1021/jp2076337

[38]

Caglayan Sci. Transl. Med. (2014) 10.1126/scitranslmed.3007747

[39]

Huse J. Biol. Chem. (2002) 10.1074/jbc.m111141200

[40]

Liu Acta Neuropathol. (2006) 10.1007/s00401-006-0077-5

[41]

Hosoda J. Neuropathol. Exp. Neurol. (1998) 10.1097/00005072-199811000-00012

[42]

Gomez-Ramos J. Alzheimer's Dis. (2007) 10.3233/jad-2007-11109

[43]

Wirths Neurosci. Lett. (2001) 10.1016/s0304-3940(01)01876-6

[44]

Cirrito Neuron (2005) 10.1016/j.neuron.2005.10.028

[45]

Kamenetz Neuron (2003) 10.1016/s0896-6273(03)00124-7

[46]

Morley J. Alzheimer's Dis. (2010) 10.3233/jad-2010-1230

[47]

Ghiso Adv. Drug Delivery Rev. (2002) 10.1016/s0169-409x(02)00149-7

[48]

Strozyk Neurology (2003) 10.1212/01.wnl.0000046581.81650.d0

[49]

Scheuner Nat. Med. (1996) 10.1038/nm0896-864

[50]

Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

Igor V. Kurochkin, Sataro Goto

FEBS Letters 1994 10.1016/0014-5793(94)00387-4

Showing 50 of 524 references

Cited By

309

Generation of Membrane-Damaging hIAPP Oligomers via Direct Interaction with DOPC/DOPS Nanodiscs

Dipanwita Roy, Satadru Chakraborty · 2026

Langmuir

Computational insights into the aggregation mechanism of human calcitonin

Fengjuan Huang, Xinjie Fan · 2025

International Journal of Biological...

Natural Polyphenolic Nanodots for Alzheimer's Disease Treatment

Peng Yang, Qianqian Huang · 2023

Advanced Materials

Graphene quantum dots obstruct the membrane axis of Alzheimer's amyloid beta

Huayuan Tang, Yuhuan Li · 2022

Physical Chemistry Chemical Physics

Tailoring Peptide Self-Assembly and Formation of 2D Nanoribbons on Mica and HOPG Surface

Hao Kong, Bin Liu · 2022

Materials

Interactions of the Aβ(1–42) Peptide with Boron Nitride Nanoparticles of Varying Curvature in an Aqueous Medium: Different Pathways to Inhibit β-Sheet Formation

Nidhi Sorout, Amalendu Chandra · 2021

The Journal of Physical Chemistry B

Half a century of amyloids: past, present and future

Pu Chun Ke, Ruhong Zhou · 2020

Chemical Society Reviews

Conventional Molecular Dynamics and Metadynamics Simulation Studies of the Binding and Unbinding Mechanism of TTR Stabilizers AG10 and Tafamidis

Shuangyan Zhou, Siyu Ge · 2020

ACS Chemical Neuroscience

Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation

Dana Laor, Dorin Sade · 2019

Nature Communications

Metrics

309

Citations

524

References

Details

Published: Jan 01, 2017
Vol/Issue: 46(21)
Pages: 6492-6531

Authors

P

Pu Chun Ke

ARC Center of Excellence in Convergent Bio-Nano Science and Technology; Monash Institute of Pharmaceutical Sciences; Monash University; Parkville; Australia

M

Marc-Antonie Sani

School of Chemistry; Bio21 Institute; The University of Melbourne; Parkville; Australia

F

Feng Ding

Department of Physics and Astronomy; Clemson University; Clemson; USA

A

Aleksandr Käkinen

ARC Center of Excellence in Convergent Bio-Nano Science and Technology; Monash Institute of Pharmaceutical Sciences; Monash University; Parkville; Australia

I

Ibrahim Javed

ARC Center of Excellence in Convergent Bio-Nano Science and Technology; Monash Institute of Pharmaceutical Sciences; Monash University; Parkville; Australia

F

Frances Separovic

School of Chemistry; Bio21 Institute; The University of Melbourne; Parkville; Australia

T

Thomas P. Davis

ARC Center of Excellence in Convergent Bio-Nano Science and Technology; Monash Institute of Pharmaceutical Sciences; Monash University; Parkville; Australia

R

Raffaele Mezzenga

ETH Zurich; Department of Health Science & Technology; 8092 Zurich; Switzerland

Cite This Article

Pu Chun Ke, Marc-Antonie Sani, Feng Ding, et al. (2017). Implications of peptide assemblies in amyloid diseases. Chemical Society Reviews, 46(21), 6492-6531. https://doi.org/10.1039/c7cs00372b

Implications of peptide assemblies in amyloid diseases

You May Also Like